Related Experiment Video

Updated: Jul 8, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K

Continued Progress in the Development of Safe and Effective RSV Immunizations

Amanda C Cohn1, Aron J Hall1

  • 1From the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta.

The New England Journal of Medicine
|December 13, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.8K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Related Experiment Videos

Last Updated: Jul 8, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.8K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Related Concept Videos

Vaccinations01:51

Vaccinations

44.6K
Overview
44.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Development of Immunocompetence01:22

Development of Immunocompetence

312
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
312

Articles linked to this work by shared authors, journal, and citation graph.

Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024.

JAMA internal medicine·2026

Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.

MMWR. Morbidity and mortality weekly report·2025

Comparison and bias analysis of medically attended acute gastroenteritis incidence estimates derived from electronic health record surveillance versus cross-sectional surveys.

PloS one·2025

Seasonality of medically attended norovirus gastroenteritis and its association with climatic factors within an US integrated healthcare system, 2016-2019.

PloS one·2025

Incidence of Norovirus-Associated Acute Gastroenteritis across Age Groups in a Peruvian Andean Community.

The American journal of tropical medicine and hygiene·2025

A framework for monitoring RSV prevention product effectiveness in the United States.

Vaccine·2025

Syncope.

The New England journal of medicine·2026

Effects of self-care intervention using a mobile instant messenger on hemodialysis patient's knowledge, self-efficacy, self-care behavior and physiological index.

Journal of Korean biological nursing science·2026

Exploring Adolescent Girls' and Young Women's Perceptions of HIV Prevention Pre-exposure Prophylaxis Use: A Qualitative Synthesis of Evidence from Sub-Saharan Africa.

AIDS and behavior·2026

Gendered Patterns of Engagement With NHS Health Checks in a Super-Diverse City: Community Perspectives and Implications for Equity.

Public health challenges·2026

Integrating Home-Based Palliative Care Into Primary Healthcare in Jodhpur, Rajasthan: Stakeholder-Perceived Barriers, Facilitators, and System Needs.

Cureus·2026

Effectiveness of pharmacist-led management of candidemia in a tertiary care hospital without a full-time infectious disease specialist.

Nagoya journal of medical science·2026

Postpartum family planning education during prenatal care: a cross-sectional study using descriptive statistics in Barrero, Dominican Republic.

Frontiers in global women's health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us